Chile · Delayed Price · Currency is CLP Salmones Camanchaca Earnings Call Transcripts
Fiscal Year 2025
-
Operational revenue dropped 26% year-over-year in Q2 2025 due to planned coho harvest reductions, but cost efficiencies and higher prices for both species drove a 50%+ increase in adjusted EBITDA. Net debt fell 23%, and the company expects accelerated harvests and price recovery in 2026.
-
First quarter 2025 saw a 27% increase in harvest and a fourfold rise in EBITDA, driven by cost reductions and improved biological results, despite an 11% revenue drop from planned coho reductions. Net debt fell over 30%, and the company projects strong growth and lower financial expenses ahead.
Fiscal Year 2024
-
Q4 2024 saw a 27% revenue increase and strong EBITDA growth, driven by higher Atlantic and Coho volumes, cost reductions, and improved biological results. Net debt fell, and guidance points to further harvest growth in 2025–2026, with stable market prices expected.
-
Q3 2024 saw EBITDA triple year-over-year to $9.2 million, driven by lower production costs and strong biological performance, despite a 12% revenue drop. Net profit reached $4.1 million, and harvest guidance for 2024 and 2025 remains on track.
-
Q2 2024 saw a 50% revenue increase year-over-year, driven by higher Atlantic salmon harvests, despite significant price declines. Cost reductions, strong biological performance, and non-recurrent gains supported margins, while market and currency headwinds persisted.